FDA
label_change
· 2008-02-13
FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)
Summary
The FDA approved a supplemental application for EMSAM (selegiline transdermal patch) from Viatris Specialty LLC. This action updates the product labeling for EM…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EMSAM (SELEGILINE)